The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVH.L Regulatory News (CVH)

  • There is currently no data for CVH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

1 Dec 2010 16:16

RNS Number : 2114X
Cavanagh Group PLC
01 December 2010
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Cavanagh Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Simon Redgrove

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

29/11/10

6. Date on which issuer notified:

29/11/10

7. Threshold(s) that is/are crossed orreached: vi, vii

21%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0030907850

2,361,421

2,361,421

2,536,859

2,536,859

21.88%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction N/A

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2,536,859

21.88%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Andrew Fay

15. Contact telephone number:

01444475400

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAKAFEFSEFFF
Date   Source Headline
13th Nov 20237:00 amRNS3rd Quarter and 9 Month Results
6th Nov 20233:10 pmRNSExpected Delisting of Global Depositary Shares
11th Aug 20237:28 amRNSFirst Half and Second Quarter 2023 Results
11th May 20238:16 amRNS1st Quarter Results
4th May 202310:16 amRNSPayment of Dividends in kind
4th May 202310:15 amRNSAudit Committee
2nd May 20237:00 amRNSDirectorate Information
2nd May 20237:00 amRNSAGM Statement
2nd May 20237:00 amRNSAnnual Financial Report
20th Apr 20238:01 amRNSCNV Approves Subsidiary Merger Prospectus
14th Apr 20237:00 amRNSResponse to Shareholder Information Request
23rd Mar 20233:00 pmRNSCVH Calls Annual Shareholders’ Meeting
14th Mar 202311:11 amRNSLeave of Absence
13th Mar 20234:56 pmRNSFull Year and Last Quarter 2022 Results
13th Mar 20237:00 amRNSBoard of Directors Approves Subsidiary Merger
6th Mar 20237:00 amRNSWebcast to discuss 4Q and FY 2022 results
20th Feb 20237:00 amRNSComposition of Audit Committee
16th Jan 20236:15 pmRNSSecretary of Trade imposes Fine on Subsidiary
7th Dec 20227:00 amRNSDirectorate Change
7th Dec 20227:00 amRNSClass “A” Shareholders’ Meeting
23rd Nov 20226:21 pmRNSNotice of Class "A" Shareholders' Meeting
23rd Nov 20226:19 pmRNSPresident of the Board Tenders Resignation
18th Nov 20227:28 amRNSPresident of the Board Tenders Resignation
11th Nov 20227:57 amRNSNine months and Third Quarter 2022 Results
31st Oct 20228:07 amRNSNotice of Results
11th Aug 20227:32 amRNSFirst Half and Second Quarter 2022 Results
25th Jul 20226:21 pmRNSNotice of Results
12th Jul 20227:48 amRNSPayment of Dividends in Kind
11th Jul 20229:02 amRNSAnnual Shareholders’ Meeting
11th Jul 20228:58 amRNSPayment of Dividends in Kind
5th Jul 20223:03 pmRNSAmended and Restated Deposit Agreement
5th Jul 20221:03 pmRNSResponse to Shareholder information Request
23rd Jun 20227:29 amRNSResponse to Shareholder Information Request
6th Jun 20227:00 amRNSBoard Calls Extraordinary Shareholders' Meeting
12th May 20227:00 amRNS1st Quarter 2022 Results
4th May 20227:50 amRNSMembership of Audit Committee
3rd May 20227:00 amRNSWebcast presentation to discuss 1Q 2022 results
29th Apr 20228:23 amRNSList of the Company Authorities
29th Apr 20228:19 amRNSAGM Statement
14th Apr 20227:00 amRNSResponse to Shareholder Information Request
14th Apr 20227:00 amRNSResignation of Member of Supervisory Committee
18th Mar 20221:05 pmRNSCVH Calls Annual Shareholders' Meeting
16th Mar 20227:04 amRNSAppointment of alternate market relations officer
11th Mar 20228:56 amRNSFull Year and Last Quarter 2021 Results
18th Feb 20228:40 amRNSSupreme Court dismisses Government Appeal
10th Nov 20217:50 amRNSNine months and Third Quarter 2021 Results
2nd Sep 202111:44 amRNSCVH Announces Payment of Dividends in Kind
2nd Sep 202111:24 amRNSCVH announces payments of dividends in kind
2nd Sep 202111:22 amRNSCVH Holds Extraordinary Shareholders Meeting
23rd Aug 20217:00 amRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.